Sarasota, Florida
Clinical Associate Professor
Department of Clinical Sciences (Vascular Surgery)
Florida State University Medical School
President
Mote Vascular Foundation, Inc.
SCHEDULE FOR VEITHsymposium™
Wednesday, November 14, 2012
Presenter
SESSION 6: ENDOVENOUS TREATMENT OF VARICOSE VEINS AND OTHER HOT VENOUS TOPICS - PART 2 (5-MINUTE TALKS)
What Drugs Should We Be Using For DVT Treatment?
4:06 PM - 4:11 PM
Thursday, November 15, 2012
Presenter
SESSION 23: LOWER EXTREMITY ADDITIONAL TOPICS (4-MINUTE TALKS)
Improved 3-Year Patency Of Heparin Bonded PTFE Grafts vs. PTFE Grafts Without Heparin
1:50 PM - 1:54 PM
Friday, November 16, 2012
Presenter
SESSION 32: PROGRESS IN THE TREATMENT OF VENOUS DISEASE – PART 1B (5-MINUTE TALKS)
The New Antithrombotic Drugs: When Should They Be Used And When Shouldn’t They
11:35 AM - 11:40 AM
Saturday, November 17, 2012
Presenter
SESSION 43: FUTURE ISSUES REGARDING HEALTH CARE; CONFLICT OF INTEREST; GOVERNMENT; INDUSTRY RELATIONS; BUSINESS OF MEDICINE; PRACTICE COSTS; AND REIMBURSEMENTS (5-MINUTE TALKS)
What Is Happening With The Physician-Industry Relationship In Community Practice
11:08 AM - 11:13 AM
Presenter
SESSION 48: VASCULAR DISEASE NATURAL HISTORY; MEDICAL TREATMENT; PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
How Should We Interpret The JUPITER Trial Showing The Value Of Statins: Has JUPITER Gotten A Bum Rap?
3:46 PM - 3:51 PM
Sunday, November 18, 2012
Presenter
SESSION 54: NEW DEVELOPMENTS IN CAROTID DISEASE TREATMENT AND ASSOCIATED ISSUES (5-MINUTE TALKS)
DEBATE: A Shunt Should Never Be Used During CEA: What Is Required To Use The No-Shunt Technique Safely
10:36 AM - 10:41 AM
Presenter
SESSION 56: NEW HORIZONS, NEW CONCEPTS AND LATE BREAKING DEVELOPMENTS (5-MINUTE TALKS)
Can Medical Treatments Decrease AAA Growth Rates: Prospects For The Future
3:02 PM - 3:07 PM
 
previous next